Evidence map›Paper›PMID 39133024›Full record

ArticleAntimicrobial agents and chemotherapy2024

Plasmid-mediated acquisition and chromosomal integration of

Kohji Komori, Kotaro Aoki, Sohei Harada, Yoshikazu Ishii, Kazuhiro Tateda

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. ZoonoticEmerging microbes & infections · 2026
    Article
  2. Article
  3. Cross-sectoral sharing of CTX-M-producingMicrobiology spectrum · 2026
    Article
  4. Plasmid-Driven Resistome Diversity in 9700Antibiotics (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Emergence of Transferable Plasmid Coharboring mcr-1.1 and blaTransboundary and emerging diseases · 2026
    Article
  7. Review
  8. Frontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kohji KomoriDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-9659-3186
Kotaro AokiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.ORCID 0000-0002-9237-1217
Sohei HaradaDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.ORCID 0000-0003-3073-6564
Yoshikazu IshiiDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-1943-4648
Kazuhiro TatedaDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) JP18K08452Ministry of Health, Labor and Welfare of Japan H30-Shokuhin-Ippan-006, 21KA1004Project Research Grant of Toho University 22-7
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

beta-LactamasesDrug Resistance, Multiple, BacterialEscherichia coliAnti-Bacterial AgentsChromosomes, BacterialEscherichia coli InfectionsEscherichia coli ProteinsHumansJapanMicrobial Sensitivity TestsPhylogenyPlasmidsWhole Genome SequencingAnti-Bacterial Agentsbeta-lactamase CTX-M-14beta-LactamasesEscherichia coli ProteinsblaCTX-M-14chromosomal integrationEscherichia coliextended-spectrum β-lactamase (ESBL)ST131-H30

Identifiers

PMID39133024
PMCPMC11373201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.